ONLINE: PD and Medication: What’s New?
Tuesday, April 14, 2020, 1:00pm ET
Fernando Pagan, MD
Vice Chairman, Department of Neurology
Director, Movement Disorders Program
Medical Director, Georgetown University Hospital Medical Director (Parkinson’s Foundation Center of Excellence)
Dr. Fernando L. Pagán is a Professor and Vice Chairman in the Department of Neurology at Georgetown University Hospital. He received his medical degree from Georgetown University, completed an internal medicine internship and a Neurology residency at Georgetown University Hospital. In addition, Dr. Pagan completed a fellowship in Movement Disorders and Magnetic Resonance Spectroscopy at the National Institute of Neurological Diseases and Stroke within the National Institutes of Health. He is a board certified Neurologist. He is the director of the Movement Disorders Program and the Medical Director of the GUH National Parkinson Foundation Center of Excellence. He is the fellowship director for the clinical research fellowship in movement disorders at GUH. His special interests include Parkinson’s disease, parkinsonism and other related disorders, ataxia, essential tremor, dystonia and tics. He is an expert in Botulinum Toxin treatment for dystonia, tremor, spasticity and tics. He is a member of the functional neurosurgery team for movement disorders, performing preoperative evaluations and programming for deep brain stimulators in Parkinson’s disease, essential tremor and dystonia. Dr. Pagan is the Medical director of the Translational Neuratherapeutics Program at Georgetown University Medical Center. This group aims to study the effects of chemotherapeutic drugs in stopping the progression of neurodegenerative disorders like Parkinson's Disease, Parkinson's related disorders, Alzheimer's Disease, Huntington's Disease, and ALS. He has been the primary investigator of numerous clinical trials and is currently the primary investigator of 15 clinical research trials aimed at discovering new drugs or approaches to improving the quality of life of patients with movement and neurodegenerative disorders.
- Understand the pathology behind Parkinson
- Describe Parkinson’s as a motor and non-motor disease
- Review classes of medical and surgical treatments for motor and non-motor symptoms
- Briefly overview how research is trying to target the underlying pathology
We have multiple medications to help improve quality of life of individuals with Parkinson’s disease. Although, do medicines change the course of Parkinson’s? Every person is different; what works for one may not necessarily work for another. In this webinar, Dr. Fernando Pagan will review the effects of medications used to treat Parkinson’s disease for both motor and non-motor symptoms and will share the effects and progress one may experience with these treatments.